1.Effect of tirofiban on levels of serum soluble CD40 ligand in elderly patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention
Pingshuan DONG ; Hongxiao KAI ; Laijing DU
Chinese Journal of Interventional Cardiology 1996;0(01):-
0. 05). Level of sCD40L was significantly decreased in the tirofiban group after PCI compared with the control (3.17?1.01 ?g/L vs 4.05?0.96 ?g/L, P
2.The Prognostic Effect of Left Ventricular End-diastolic Pressure During Primary Percutaneous Coronary Intervention in Patients With Acute ST-segment Elevation Myocardial Infarction
Jingjing JIA ; Pingshuan DONG ; Laijing DU ; Zhijuan LI ; Ximei FAN ; Honglei WANG ; Xishan YANG ; Xuming YANG
Chinese Circulation Journal 2015;(6):543-546
Objective: To evaluate the post-operative mortality of left ventricular end-diastolic pressure (LVEDP) during primary percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI). Methods: We retrospectively analyzed 255 patients with new onset of STEMI who received primary PCI in our hospital and all patients received LVEDP measurement before coronary artery opening. According to LVEDP value, the patients were divided into 2 groups: LVEDP≤14 mmHg group,n=155 and LVEDP>14 mmHg group,n=100. The post-operative mortality up to 6 months was observed, and the effect of LVEDP on death rate was studied by Cox regression analysis. Results: Compared with LVEDP≤14 mmHg group, the patients in LVEDP>14 mmHg group had the 6 months mortality at HR=4.26, 95% CI (1.13-16.08),P=0.03. Relevant study presented that LVEDP was slightly related to LVEF (r=-0.267, P=0.001) and BNP (r=-0.154,P=0.041). Multi-regression analysis indicated that with adjusted LVEF and BNP, LVEDP was the independent predictor for post-operative mortality up to 6 months in acute STEMI patients after PCI. Conclusion: The LVEDP value measured during PCI procedure is the independent predictor for mortality after PCI in patients with new onset of STEMI.
3.Ultrasound diagnosis of abdominal cocoon
Shengjiang CHEN ; Ling QIN ; Laijing DU ; Fang ZHANG ; Jinfeng WANG ; Wang CHEN ; Zhoulong ZHANG ; Mei CHEN
Chinese Journal of Ultrasonography 2009;18(8):695-697
AC.
4.Effects of different reperfusion strategies on clinical outcome of ST-segment elevation myocardial ;infarction patients
Pingshuan DONG ; Zhijuan LI ; Hongqiang DUAN ; Laijing DU ; Honglei WANG ; Ke WANG ; Peng YAN ; Xiyan SHANG ; Ximei FAN ; Ruiqing LIU ; Qiuling ZHAI ; Baoxia XIANG
Chinese Journal of Interventional Cardiology 2014;(3):172-175
Objective To evaluate the outcome of ST-segment elevation myocardial infarction (STEMI) patients received different reperfusion therapies. Methods The 238 consecutive STEMI patients were enrolled from February 2012 to December 2012. According to the current guideline of PCI and the choice of patients, the patients were divided into the groups of percutaneous coronary intervention (PCI), ifbrinolysis, and conservative medication. The major adverse cardiac events (MACE) was analyzed in a follow up of 6 months. Results (1) The enrolled patients included the 210 patients received PCI (88.2%), 14 patients received fibrinolysis (5.9%) and 14 patients received conservative medication (5.9%).The Median time of D2B was 110minutes.(2) The rate of late stent thrombosis was signiifcant higher in BMS than DES (n=2, 2.8%vs 0, P < 0.05) . (3) The PCI group had a signiifcantly higher incidence of stroke than the ifbrinolysis group and the conservative medication group (1.0%vs 0, P < 0.05;1.0%vs 0, P<0.05). (4) The PCI group had a signiifcantly higher incidence of bleeding compared to the thrombolysis group and the medication group (1.0% vs 0, P < 0.05; 1.0% vs 0%, P < 0.05). Conclusions The majority of STEMI patients received PCI;The D2B time, which was required<90 minutes in guideline of PCI, was found delayed in our study;Compared to ifbrinolysis and conservative medication, PCI showed better clinical outcomes of STEMI patients.